Get a Group Membership for your Organization. Free Trial
Pricing
Free TrialLogin

BI-RADS 6 – Right Breast Cancer, No Other Findings

HIDE
PrevNext

0:01

Our next group of patients was

0:02

coded as BI-RADS category six.

0:06

Our first case is a 77-year-old woman

0:09

with a recent diagnosis of right

0:11

breast invasive lobular carcinoma.

0:13

We did an MRI to assess extent of disease.

0:18

So here's the MIP for this patient,

0:20

demonstrating a large irregular enhancing mass

0:23

here in the right anterior lateral breast.

0:28

And the rest of the breast

0:29

tissue is pretty quiet.

0:31

We'll go ahead and look at

0:32

some of the other sequences.

0:35

Pull in our T1, our subtracted

0:38

image, and you can see that there's

0:43

an irregular enhancing mass here.

0:46

There's a circle around the mass with the

0:48

susceptibility artifact from her biopsy

0:50

clip here on the T1-weighted sequence.

0:54

And we went through this whole case.

0:59

She does have a few little enhancing

1:02

foci here and there, but nothing

1:05

suspicious in either breast.

1:09

And surprisingly, even with this three

1:13

centimeter known carcinoma in the

1:15

right breast, there really weren't

1:18

suspicious lymph nodes that

1:20

we were concerned about.

1:21

So let me go ahead and look at

1:23

some of the other sequences.

1:26

So here's T1,

1:29

a pre- and post-contrast source images,

1:33

And just demonstrating that enhancing mass

1:37

again with the artifact from the biopsy

1:40

clip and no other suspicious findings.

1:46

So the patient ended up having a successful

1:51

lumpectomy on the right side and she did

1:56

have sentinel node biopsies and the sentinel

2:00

nodes were negative for metastatic disease.

2:03

So that was a great outcome for her.

Report

Description

Faculty

Lisa Ann Mullen, MD

Assistant Professor; Breast Imaging Fellowship Director

Johns Hopkins Medicine

Tags

Women's Health

Neoplastic

MRI

Breast

© 2024 MRI Online. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy